Skip to content

Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07464730
Acronym
Hi-POP
Enrollment
200
Registered
2026-03-11
Start date
2026-03-09
Completion date
2029-03-09
Last updated
2026-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pulmonary Complications (PPCs)

Keywords

HFNO, High flow nasal oxygen, Postoperative pulmonary complication

Brief summary

High flow nasal oxygen (HFNO) in the immediate postoperative period has been demonstrated to reduce the risk of postoperative pulmonary complications (PPC) after cardiothoracic surgery. In specific groups of patients such as the obese and after upper abdominal surgery the results are contradictive. However, there is lack of evidence if HFNO in the general high-risk patient after abdominal and non-cardiac thoracic surgery can reduce the prevalence of PPC, hypoxaemia and escalation of therapy. Therefore, the investigators aim to compare the use of HFNO with conventional oxygen therapy (COT) in high-risk patients after abdominal and non-cardiac thoracic surgery regarding postoperative pulmonary complications.

Interventions

COMBINATION_PRODUCTHigh Flow Oxygen

High flow nasal oxygen will be administered in the intervention group

COMBINATION_PRODUCTOxygen

Oxygen delivered by nasal cannula or oxymask

Sponsors

Region Stockholm
Lead SponsorOTHER_GOV
Karolinska Institutet
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults (≥18 years old) scheduled for elective abdominal (laparotomy or laparoscopy), open abdominal vascular or non-cardiac thoracic surgery under general anaesthesia with an estimated duration over 3 hours. AND Meeting at least two of the following criteria: * Age \> 65 years * BMI \>30 * Preoperative SpO2 \<95 % * Scheduled for lobectomy or pulmonary segment resection * Respiratory tract infection the last month * Preoperative anaemia (Hb \<100) or severe hypoalbuminemia (\<20 g/L) * Current smoker or previous smoker with \>30 packyears * Pulmonary disease or OSAS * Heart failure * Clinical frailty (CFS 4)

Exclusion criteria

* Not suitable for postoperative HFNO, as decided by a study member or the anaesthetist in charge (such as total nasal obstruction, skull fracture, facial injuries) * Pregnancy * Not able to understand the study information or sign an informed consent. * Not able to participate with the treatment postoperatively * Planned for delayed extubation in the intensive care * Preoperative non-invasive ventilation due to respiratory failure or a higher level of care than a regular ward

Design outcomes

Primary

MeasureTime frame
Frequency of postoperative pulmonary complications (PPC) the first seven days after high-risk abdominal or non-cardiac thoracic surgery in high-risk patients with high-flow nasal oxygen or conventional oxygen therapy in the immediate postoperative periodUp to 7 days after surgery

Secondary

MeasureTime frameDescription
Mortality in hospitalUp until 30 days after surgeryMortality during hospital admission after surgery
30-days mortality30 days after surgery30-days mortality, number and proportion of patients between the groups
Healthy days at home 30 days after surgery30 days postoperativelyNumber of healthy days at home 30 days after surgery compared between the groups
Lowest SpO2 the first 2 and 24 h after randomisation24 hours after randomisationLowest oxygen saturation registered in the chart during the first 2 and 24 h after randomisation
Desaturation (SpO2 <90%) the first 2 or 4 and under 24 hours after randomisationFirst 24 hours after randomisationProportion of patients that has a registered oxygen saturation under 90% 2, 4 and 24 hours after randomisation
Lowest PaO2/FiO2 ratio during the intervention periodMaximum 4 hours after start of intervention postoperativelyComparison of the lowest PaO2 and FiO2 (fraction of inspired oxygen) during the intervention period ( i e 2 or 4 hours depending of the result from the air test)
Subjective patient comfort (visual scale 0-10)Maximum 4 hours after start of interventionPatients will report their comfort with each method, HFNO or COT after the intervention
Length of stay in hospitalFrom surgery up until 30 days after surgeryThe length of stay in hospital after surgery will be recorded and compared
Length of stay (LOS) in the postoperative unitUp to 7 days after surgeryThe duration of stay in the postoperative unit will be registered and compared between the groups

Countries

Sweden

Contacts

CONTACTIda-Maria Forsberg, PhD
ida-maria.forsberg@regionstockholm.se+46704381445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026